209 related articles for article (PubMed ID: 35084549)
1. Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomas.
Duan W; Zhang B; Li X; Chen W; Jia S; Xin Z; Jian Q; Jian F; Chou D; Chen Z
Cancer Immunol Immunother; 2022 Sep; 71(9):2185-2195. PubMed ID: 35084549
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
[TBL] [Abstract][Full Text] [Related]
3. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
[TBL] [Abstract][Full Text] [Related]
4. Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma.
Wu H; Li X; Zhang B; Liu P; Qi M; Du Y; Zhang C; Duan W; Chen Z
Br J Cancer; 2024 Jun; 130(10):1609-1620. PubMed ID: 38605247
[TBL] [Abstract][Full Text] [Related]
5. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
[TBL] [Abstract][Full Text] [Related]
7. Molecular features and vulnerabilities of recurrent chordomas.
Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment.
Baluszek S; Kober P; Rusetska N; Wągrodzki M; Mandat T; Kunicki J; Bujko M
Acta Neuropathol Commun; 2023 Jul; 11(1):113. PubMed ID: 37434245
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma.
Jin X; Wang Q; Luo F; Pan J; Lu T; Zhao Y; Zhang X; Xiang E; Zhou C; Huang B; Lu G; Chen P; Shao Y
Chin Med J (Engl); 2023 Mar; 136(6):690-706. PubMed ID: 36939254
[TBL] [Abstract][Full Text] [Related]
10. Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma.
Gulluoglu S; Sahin M; Tuysuz EC; Yaltirik CK; Kuskucu A; Ozkan F; Sahin F; Ture U; Bayrak OF
Oncol Res; 2017 Aug; 25(7):1177-1188. PubMed ID: 28247842
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
[TBL] [Abstract][Full Text] [Related]
12. PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.
Mathios D; Ruzevick J; Jackson CM; Xu H; Shah SR; Taube JM; Burger PC; McCarthy EF; Quinones-Hinojosa A; Pardoll DM; Lim M
J Neurooncol; 2015 Jan; 121(2):251-9. PubMed ID: 25349132
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cancer stem-like cells in chordoma.
Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U
J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189
[TBL] [Abstract][Full Text] [Related]
14. Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
Schwab JH; Boland PJ; Agaram NP; Socci ND; Guo T; O'Toole GC; Wang X; Ostroumov E; Hunter CJ; Block JA; Doty S; Ferrone S; Healey JH; Antonescu CR
Cancer Immunol Immunother; 2009 Mar; 58(3):339-49. PubMed ID: 18641983
[TBL] [Abstract][Full Text] [Related]
15. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical investigation of chordomas: histogenetic and differential diagnostic aspects.
Bouropoulou V; Bosse A; Roessner A; Vollmer E; Edel G; Wuisman P; Härle A
Curr Top Pathol; 1989; 80():183-203. PubMed ID: 2776494
[TBL] [Abstract][Full Text] [Related]
17. Chordoma: the nonsarcoma primary bone tumor.
Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity.
Mori K; Chano T; Kushima R; Hukuda S; Okabe H
Virchows Arch; 2002 Feb; 440(2):123-127. PubMed ID: 11964040
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas.
Bell AH; DeMonte F; Raza SM; Rhines LD; Tatsui CE; Prieto VG; Fuller GN; Bell D
Virchows Arch; 2018 Mar; 472(3):489-497. PubMed ID: 28844110
[TBL] [Abstract][Full Text] [Related]
20. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]